Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti‐<scp>TNF</scp> medications

Khan, Nabeel; Shah, Yash; Trivedi, Chinmay; Lewis, James D.

doi:10.1111/apt.14257

Cited by 24 publications

(16 citation statements)

References 21 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…These recommendations are in line with the recommendations by the Infectious Disease Society of America [47]. Besides, a recent study by Khan et al [68] suggests that even among patients on anti-TNF medication vaccination with the live vaccine may be safe. However, only around 21% of patients eligible for vaccination were vaccinated, as a recent study by Khan et al [69] showed.…”

Section: Human Papillomavirussupporting

confidence: 72%

Vaccination in Patients with Inflammatory Bowel Diseases

Manser

Maillard²,

Rogler

et al. 2020

Digestion

View full text Add to dashboard Cite

show abstract

Section: Human Papillomavirussupporting

confidence: 72%

Vaccination in Patients with Inflammatory Bowel Diseases

Manser

Maillard²,

Rogler

et al. 2020

Digestion

View full text Add to dashboard Cite

show abstract

“…Therefore, the vaccine needs to be given ≥3 weeks prior to the initiation of any immunosuppressant medication [44]. However, Khan et al showed that, in 59 patients treated with anti-TNF medication, of whom 12 (20%) were also using thiopurine, once they received the vaccine no case of HZ infection was seen within 0-42 days after its administration [45].…”

Section: Vaccination Rate In Ibd Patientsmentioning

confidence: 99%

Improving immunization strategies in patients with inflammatory bowel disease

Farshidpour

Charabaty

Mattar

2019

aog

View full text Add to dashboard Cite

Patients with inflammatory bowel disease (IBD) are susceptible to varieties of opportunistic infections due to immunological changes in the setting of their disease and drug-induced immunosuppression. Even though numerous infections can be prevented by vaccine, vaccination in IBD patients is inadequate. Data showed only 9% were vaccinated against pneumococcal infection and 28% described commonly receiving influenza vaccine. This review article discusses the recent immunizations against influenza virus; pneumococcal infection; human papilloma virus; tetanus, diphtheria and pertussis; measles, mumps and rubella; varicella zoster; and herpes zoster for individuals diagnosed with IBD and those patients with drug-related immunosuppression. In addition, this review discusses concerns about IBD patients planning to travel abroad. Immunization status and screening for opportunistic infection need to be addressed in IBD patients at the time of diagnosis and they should be vaccinated accordingly. Generally, standard vaccination strategies should be pursued in IBD patients, although live vaccines should be avoided while they are not immunocompetent.

show abstract

“…The prevalence of tuberculosis in Japan was 17 per 100,000 population as of 2015, which was lower than that in other Asian countries, such as 322 in the Philippines, 217 in India, 80 in South Korea, and 67 in China, yet was still higher than the low-prevalence standard of 10, as is the case in many developed countries [34]. Therefore, in many Asian countries including Japan, Bacille CalmetteGuérin (BCG) is generally administered during infancy.…”

Section: Bacille Calmette-guérinmentioning

confidence: 68%

Prevention of Infectious Diseases due to Immunosuppression and Vaccinations in Asian Patients with Inflammatory Bowel Disease

Sagami

Hibi

2018

Inflamm Intest Dis

View full text Add to dashboard Cite

Background: Inflammatory bowel disease (IBD) patients with immunocompromise have a high risk of developing complications related to viral infections. Western countries were the first to formulate vaccine guideline. Asian countries developed their national and international vaccine guidelines a little later in order to reduce the risk of mortality from viral infections. However, no studies to date have examined the differences in vaccinations that prevail among Asian countries. Summary: This review summarizes the vaccination status and schedules in various Asian countries for immunocompromised IBD patients. Vaccination rates, regardless of the specific vaccine, were high in Japan, South Korea, and China and low in India and the Philippines. Vaccine schedules differed by country, and outbreaks of measles and rubella were seen due to low vaccination rates in Southeast Asia and South Asia. Live vaccines cannot be administered during immunosuppressive treatment. Infection with measles, mumps, and varicella during immunosuppressive therapy carries a high risk of mortality, and thus confirmation of immunization status is recommended as soon as IBD is diagnosed and, when possible, live vaccines should be administered before the initiation of immunosuppressive treatment. In patients seronegative for hepatitis B, administration of the hepatitis B vaccine is also recommended. Key Messages: Physicians, while considering severity of outbreaks, should understand the differences in vaccination status that exist among the various Asian countries and regions.

show abstract

Safety of herpes zoster vaccination among inflammatory bowel disease patients being treated with anti‐TNF medications

Cited by 24 publications

References 21 publications

Vaccination in Patients with Inflammatory Bowel Diseases

Vaccination in Patients with Inflammatory Bowel Diseases

Improving immunization strategies in patients with inflammatory bowel disease

Prevention of Infectious Diseases due to Immunosuppression and Vaccinations in Asian Patients with Inflammatory Bowel Disease

Contact Info

Product

Resources

About